NCT02179008 Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE2
NCT02167035 Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID) Status COMPLETED Phase PHASE4
NCT02165631 The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure Status COMPLETED Phase N/A
NCT02143843 An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product Status COMPLETED Phase PHASE2
NCT02140060 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE2
NCT02136940 Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE2
NCT02129673 A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE1/PHASE2
NCT02108288 Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers Status COMPLETED Phase PHASE1
NCT02105285 Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT02105272 Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT02102750 A Study to Evaluate Pharmacokinetics of Tafluprost Ophthalmic Solution (0.0015%) in Pediatric Patients With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE1
NCT02097719 Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE4
NCT02083289 A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG) Status COMPLETED Phase PHASE2
NCT02061683 A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension Status COMPLETED Phase PHASE4
NCT02059278 Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT02057575 Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure Status COMPLETED Phase PHASE2
NCT02047630 Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension Status TERMINATED Phase PHASE4
NCT02030886 IOP Patterns in Ocular Hypertensive Patients Newly Converted to Glaucoma vs Stable Ocular Hypertensive Patients Status TERMINATED Phase NA
NCT02020512 A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension Status COMPLETED Phase PHASE4
NCT02017327 Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose Status COMPLETED Phase PHASE4